Ortho Clinical Diagnostics Holdings PLC Stock News

The shares of Ortho Clinical Diagnostics Holdings PLC (NASDAQ:OCDX) are up 8.1% to trade at $21.45 last check, after news that Quidel (QDEL) will acquire the company for roughly $6 billion in a cash

Find out why the stock market could see more gains.

Quidel Corp (NASDAQ: QDEL) has agreed to acquire Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX) for $24.68 per share in cash and newly issued shares in the combined company,  The offer pr

Quidel Corp. QDEL, -0.42% said Thursday it agreed to acquire Ortho Clinical Diagnostics Holdings Plc OCDX, +1.54% for $24.68 per share of common stock in cash and newly issued shares in the combined c

SAN DIEGO & RARITAN, N.J.--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”) and Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX) (“Ortho”) today announced that they have ent

Ortho Clinical Diagnostics Holdings plc (NASDAQ:OCDX) has been given a consensus recommendation of Buy by the thirteen research firms that are currently covering the stock, MarketBeat Ratings reports. Two analysts have rated the stock with a hold recommendation and eleven have given a buy recommendation to the company. The average twelve-month price target among brokers []

Global WholeHealth Partners (OTCMKTS:GWHP) and Ortho Clinical Diagnostics (NASDAQ:OCDX) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, risk, earnings, profitability, analyst recommendations and valuation. Analyst Ratings This is a breakdown of current recommendations for Global WholeHealth Partners and []

Carlyles experience investing in medical products businesses includes Medline, Ortho Clinical Diagnostics, Unchained Labs, and MicroPort, among others.

Enzyme-linked immunosorbent assay (ELISA) is a labeled immunoassay that is considered the gold standard of immunoassays. This immunological test is very sensitive and is used to detect and quantify substances, including antibodies, antigens, proteins, glycoproteins, and hormones. The enzyme-linked immunosorbent assay

This COVID-19 Diagnostic Tests market report aims to give foreseen trends as well as a comprehensive understanding of the business from many angles. This section contains information on key business profiles, price comparison, and business data for industry participants. It

RARITAN, N.J., Nov. 23, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the worlds largest pure-play in vitro diagnostics (IVD) companies, today announced that members of its management team are scheduled to participate in the 4 th Annual Evercore ISI HealthCONx Conference on Tuesday, November 30, 2021, with a fireside chat scheduled for 3:30pm ET.

As market research reports are attaining immense importance in this swiftly transforming market place, DBMR team endows with the top notch Biotechnology market research reports in a way that is anticipated. It all-inclusively estimates general market conditions, the growth prospects

UBS Asset Management Americas Inc. acquired a new stake in Ortho Clinical Diagnostics Holdings plc (NASDAQ:OCDX) in the second quarter, according to its most recent filing with the SEC. The fund acquired 71,272 shares of the companys stock, valued at approximately $1,526,000. Other hedge funds have also modified their holdings of the company. Royal Bank []

Ortho Clinical Diagnostics Holdings plc (NASDAQ:OCDX) was the target of a large decrease in short interest in October. As of October 29th, there was short interest totalling 1,490,000 shares, a decrease of 17.2% from the October 14th total of 1,800,000 shares. Currently, 1.3% of the shares of the stock are short sold. Based on an []